全文获取类型
收费全文 | 86901篇 |
免费 | 7601篇 |
国内免费 | 2107篇 |
专业分类
耳鼻咽喉 | 680篇 |
儿科学 | 2668篇 |
妇产科学 | 759篇 |
基础医学 | 5373篇 |
口腔科学 | 529篇 |
临床医学 | 13137篇 |
内科学 | 17090篇 |
皮肤病学 | 524篇 |
神经病学 | 4531篇 |
特种医学 | 4317篇 |
外国民族医学 | 2篇 |
外科学 | 8441篇 |
综合类 | 16384篇 |
预防医学 | 6043篇 |
眼科学 | 946篇 |
药学 | 8341篇 |
123篇 | |
中国医学 | 4888篇 |
肿瘤学 | 1833篇 |
出版年
2024年 | 111篇 |
2023年 | 1381篇 |
2022年 | 2570篇 |
2021年 | 3898篇 |
2020年 | 4021篇 |
2019年 | 2938篇 |
2018年 | 2650篇 |
2017年 | 3333篇 |
2016年 | 3293篇 |
2015年 | 3000篇 |
2014年 | 6093篇 |
2013年 | 5927篇 |
2012年 | 5220篇 |
2011年 | 5413篇 |
2010年 | 4479篇 |
2009年 | 4204篇 |
2008年 | 4281篇 |
2007年 | 4582篇 |
2006年 | 4057篇 |
2005年 | 3436篇 |
2004年 | 2733篇 |
2003年 | 2347篇 |
2002年 | 1948篇 |
2001年 | 1885篇 |
2000年 | 1497篇 |
1999年 | 1321篇 |
1998年 | 1042篇 |
1997年 | 959篇 |
1996年 | 792篇 |
1995年 | 909篇 |
1994年 | 808篇 |
1993年 | 616篇 |
1992年 | 656篇 |
1991年 | 522篇 |
1990年 | 455篇 |
1989年 | 396篇 |
1988年 | 384篇 |
1987年 | 356篇 |
1986年 | 275篇 |
1985年 | 300篇 |
1984年 | 290篇 |
1983年 | 161篇 |
1982年 | 227篇 |
1981年 | 151篇 |
1980年 | 120篇 |
1979年 | 137篇 |
1978年 | 129篇 |
1977年 | 79篇 |
1976年 | 75篇 |
1975年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
1.
2.
《Revista portuguesa de cardiologia》2022,41(9):783-789
Amiodarone is the most potent antiarrhythmic drug available and is commonly prescribed to treat and prevent not only life-threatening ventricular arrhythmias but also atrial fibrillation (AF). The latest European Society of Cardiology AF guidelines state that amiodarone is recommended for long-term rhythm control in all AF patients but that other antiarrhythmic drugs should be considered first whenever possible, due to its extracardiac toxicity. In patients without significant or with only minimal structural heart disease, amiodarone is not listed as a possibility in their therapeutic scheme. Still, amiodarone is widely and liberally used, and is the most prescribed antiarrhythmic drug for patients with AF despite its high toxicity profile. Non-cardiovascular death was more frequent with amiodarone treatment than with a rate control strategy in AFFIRM, while meta-analyses suggest an association between amiodarone use in patients without structural heart disease and increased non-cardiovascular mortality. Severe or even fatal outcomes due to amiodarone may occur years after treatment initiation and are often not acknowledged by the prescribing physician, who may no longer be following the patient. The lack of widely accepted diagnostic criteria and symptom definitions may lead to underestimation of the incidence of severe side effects and of its toxicity. Unlike the underestimated risk of toxicity with amiodarone, severe complications associated with catheter ablation are usually directly ascribed to the treatment even by non-medical personnel, possibly resulting in overestimation of risks. This brief review will address the issue of amiodarone overuse and the frequent underestimation of its toxicity, while suggesting scenarios in which its use is entirely reasonable, and compare it with catheter ablation. 相似文献
3.
4.
5.
6.
7.
8.
9.
《Journal of vascular and interventional radiology : JVIR》2022,33(9):1073-1082.e2
PurposeTo create a nonsurgical animal model of osteoarthritis (OA) to evaluate the effects of embolotherapy during geniculate artery embolization (GAE).Materials and MethodsFluoroscopy-guided injections of 700 mg of sodium monoiodoacetate were performed into the left stifle in 6 rams. Kinematic data were collected before and after induction. At 10 weeks after induction, Subjects 1 and 4–6 underwent magnetic resonance (MR) imaging with dynamic contrast enhancement (DCE) and Subjects 1, 3, and 4–6 underwent angiography with angiographic scoring to identify regions with greatest disease severity for superselective embolization (75–250-μm microspheres). Target vessel size was measured. At 24 weeks after angiography, DCE-MR imaging, angiography, and euthanasia were performed, and bilateral stifles were harvested. Medial/lateral tibial and femoral condylar, patellar, and synovial samples were cut, preserved, decalcified, and scored using the Osteoarthritis Research Society International criteria. The stifle and synovium Whole-Organ Magnetic Resonance Imaging Score and Multicenter Osteoarthritis Study score were determined. The volume transfer constant (Ktrans) and extracellular volume fraction (ve) were calculated from DCE-MR imaging along the lateral synovial regions of interest.ResultsThe mean gross and microscopic pathological scores were elevated at 38 and 61, respectively. Mean synovitis score was elevated at 9.2. Mean pre-embolization and postembolization angiographic scores were 5 and 3.8, respectively. Mean superior, transverse, and inferior geniculate artery diameters were 3.1 mm ± 1.21, 2.0 mm ± 0.50, and 1.6 mm ± 0.41 mm, respectively. Mean pre-embolization and postembolization cartilage and synovitis scores were elevated at 35.13 and 73.3 and 5.5 and 9.2, respectively. The Ktrans/ve values of Subjects 4, 5, and 6 were elevated at 0.049/0.38, 0.074/0.53, and 0.065/0.51, respectively. Altered gait of the hind limb was observed in all subjects after induction, with reduced joint mobility. No skin necrosis or osteonecrosis was observed.ConclusionsA nonsurgical ovine animal knee OA model was created, which allowed the collection of angiographic, histopathological, MR imaging, and kinematic data to study the effects of GAE. 相似文献